US Stock MarketDetailed Quotes
ATHE Alterity Therapeutics
- 1.4100
- +0.3200+29.36%
Close Nov 29 13:00 ET
- 1.4099
- -0.0001-0.01%
Post 17:01 ET
12.33MMarket Cap-693P/E (TTM)
1.5000High1.1600Low854.28KVolume1.1600Open1.0900Pre Close1.12MTurnover11.02%Turnover RatioLossP/E (Static)8.74MShares5.410052wk High1.37P/B10.93MFloat Cap1.001052wk Low--Dividend TTM7.75MShs Float51.5000Historical High--Div YieldTTM31.19%Amplitude1.0010Historical Low1.3100Avg Price1Lot Size
About Alterity Therapeutics Company
Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's, Huntington, Parkinson’s, and other neurological disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
Company Profile
SymbolATHE
Company NameAlterity Therapeutics
Listing DateSep 5, 2002
Founded1997
CEODr. David A. Stamler,M.D.
MarketNASDAQ
Employees10
Securities TypeDR
ADS Ratio1.0 : 600.0
Fiscal Year Ends06-30
Address350 Collins Street,Level 14,Suite 4
CityMelbourne
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3000
Phone61-3-9349-4906
Company Executives
- Name
- Position
- Salary
- Dr. David A. Stamler,M.D.
- Chief Executive Officer
- 1.42M
- Phillip A. Hains
- Company Secretary and Chief Financial Officer
- --
- Geoffrey Paul Kempler
- Chairman of the Board
- 280.00K
- Lawrence B. Gozlan
- Director
- 70.00K
- Peter A. Marks
- Independent Director
- 70.00K
- Brian Derek Meltzer
- Independent Director
- 70.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
